亚太实业(000691) - 2014 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2014 was CNY 2,966,948, a decrease of 65.31% compared to CNY 8,553,376 in the same period last year[8]. - Net profit attributable to shareholders was CNY 231,391.87, down 75.06% from CNY 927,708.01 year-on-year[8]. - The net cash flow from operating activities increased by 10.03% to CNY 4,516,694.51 from CNY 4,105,083.94 in the previous year[8]. - Total assets at the end of the reporting period were CNY 287,593,761.06, reflecting a 0.73% increase from CNY 285,518,292.44 at the end of the previous year[8]. Investment and Acquisition Plans - The company plans to raise CNY 675 million through a private placement to acquire 100% of Lanzhou Weici Pharmaceutical Co., Ltd. and invest in thrombin and traditional Chinese medicine projects[15]. - The expected acquisition price for Weici Pharmaceutical is approximately CNY 4 million, based on the net asset value determined by an asset appraisal agency[15]. - The investment amount for the thrombin and traditional Chinese medicine project is projected to be CNY 52 million[15]. Cash Flow and Receivables - Cash and cash equivalents increased by 432.99% to CNY 16,279,728.15 due to the receipt of equity transfer prepayments[14]. - The company's pre-receivable accounts rose by 460.92% to CNY 12,232,500.76, attributed to an increase in pre-received housing sales payments[14]. - Accounts payable decreased by 48.11% to CNY 11,977,393.35, primarily due to amounts not yet due for settlement[14]. Asset Management and Legal Actions - The company has recognized an impairment provision of 70 million yuan for long-term equity investments, with an expected recoverable amount of 30 million yuan[18]. - The company holds intangible assets in Tongliao City, Inner Mongolia, with a book value of 12,780,401.68 yuan, and plans to assist in the disposal of these assets[20]. - The company has committed to compensate any shortfall in asset recovery, ensuring full compensation in cash or assets if the recoverable amount is less than the book value[20]. - The company is actively pursuing legal action against Blue View Home for asset recovery, aiming to mitigate negative impacts on its financial position[22]. - The company plans to dispose of land use rights in the Inner Mongolia Tongliao Zhu Ri River Ranch, but has faced challenges due to pricing issues and land degradation[22]. Profit Expectations - The company has not provided a warning regarding significant changes in net profit for the first half of 2014, indicating stable expectations[23].